Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Recruiting 3 Unknown 1 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 32 Magnetic Resonance Spectroscopy 21 Biopsy 20 Cyclophosphamide 16 Nivolumab 10 Paclitaxel 9 Cisplatin 9 Gemcitabine 8 Bevacizumab 8 venetoclax 7 Vincristine 7 Prednisone 7 Doxorubicin 7 Azacitidine 7 pembrolizumab 6 Radiotherapy 6 Radiosurgery 6 Fluorouracil 6 Etoposide 6 Drug Therapy 6 Docetaxel 6 Taxes 5 Rituximab 5 Oxaliplatin 5 Irinotecan 5 Everolimus 5 Capecitabine 5 fludarabine phosphate 4 fludarabine 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × Niacin × Clear all

NCT04677049 2026-01-02

Study of Niacin in Glioblastoma

AHS Cancer Control Alberta

Phase 1/2 Suspended

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡